Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Capacity Expansion
59 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Capacity Expansion
Arranta Bio Announces Mechanical Completion of Commercial-Ready Capacity for Advanced Biologics
PR-M09-20-30
Cell Therapy Capacity
Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs
PR-M09-20-NI-17
Expansion
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion
PR-M09-20-NI-14
Facility
Frontida BioPharm, Inc. Announces Highly Potent Compound Contract Manufacturing Suite
PR-M08-20-NI-36
Expansion
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
PR-M08-20-NI-13
Capacity Expansion
MilliporeSigma Invests $20 Million in New Switzerland Laboratory
PR-M07-20-NI-022
Capacity Expansion
Vetter Further Expands its Development Service with New Site in Austria
PR-M07-20-NI-010
Capacity Expansion
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility
PR-M04-20-NI-032
Expansion
Novo Nordisk Invests in Upgrading and Expanding Production Facilities in Kalundborg
PR-M02-20-NI-013
Expansion
UCB to Build New Biotech Manufacturing Plant in Belgium
PR-M01-20-NI-004
Sterile Injectables
Expanding Sterile Crystallization Capabilities to Meet Rising Customer Demand
PAO-12-2019-CL-001
Investment
Lilly Announces $400 Million Capital Investment in Manufacturing Facilities in Indianapolis
PR-M11-19-NI-028
Cell and Gene Therapy
FUJIFILM Diosynth Biotechnologies Announces $55 Million Investment to Expand Gene Therapy Development Capabilities
PR-M11-19-NI-013
Facilitating Acquisitions
Facilitating Pharmaceutical and Biotech Facility Acquisitions
PAP-Q3-19-CL-021
Expansion
TriPharm Services Announces Creation of Pharmaceutical Manufacturing Center
PR-M10-19-NI-028
Opening
GENEWIZ Celebrates Opening of European Headquarters in Germany
PR-M09-19-NI-052
Investment
GSK Invests $120 million in Next-generation US Biopharmaceutical Manufacturing Facility
R-M09-19-NI-051
Expansion
Albemarle Fine Chemistry Services Expands RSM Capabilities in Tyrone, Pennsylvania
PR-M09-19-NI-025
M&A
Strides Acquires US FDA Approved Manufacturing Facility in the US
PR-M09-19-NI-018
Expansion
Aldevron Breaks Ground on 14-Acre Campus Expansion
PR-M08-19-NI-059
Expansion
Announcing Expansion for Enhanced Capabilities
PTV-M08-19-BIO-004
Capacity Expansion
GenScript Biotech's Biologics R&D and Production Center is Formally Put Into Operation
PR-M07-19-NI-075
Capacity Expansion
Kite Announces Plans to Bolster Industry-Leading Cell Therapy Manufacturing Capabilities With New Viral Vector Facility
PR-M07-19-NI-043
Acquisition
Lonza Will Purchase a Sterile Fill-Finish Site from Novartis
PAO-M07-19-NI-012
1
3
»
